Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction

Fibroblast growth factor 21 (FGF21), a polypeptide ligand promoted glucose homeostasis and lipids metabolism, was recently reported to attenuate cardiac hypertrophy. The aim of this study was to investigate the impact of FGF21 in diastolic heart failure. Subjects admitted for coronary angiogram were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Chou, Ruey-Hsing, Huang, Po-Hsun, Hsu, Chien-Yi, Chang, Chun-Chin, Leu, Hsin-Bang, Huang, Chin-Chou, Chen, Jaw-Wen, Lin, Shing-Jong
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030655/
https://ncbi.nlm.nih.gov/pubmed/27650781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep33953
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge